Alixo-yolloo CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Made in USA Inc. reports on its Q1 2026 performance, detailing a strategic pivot towards reshoring manufacturing and supply chain transparency, alongside a review of its financial condition.
OTC.Pink
Made in USA Inc. reports a strategic pivot to U.S. manufacturing reshoring and supply chain authenticity, alongside significant financial challenges including a going concern doubt and ineffective disclosure controls.
OTC.Pink
Made in USA Inc. reports Q2 net income amid a strategic pivot to US industrial reshoring, despite ongoing going concern doubts and zero cash reserves.
OTC.Pink
Alixo-Yolloo Corporation reported a significant 189% increase in revenue for the quarter ended May 31, 2025, driven by API package sales, but also saw a substantial rise in net losses and faces ongoing concerns about its ability to continue as a going concern due to insufficient capital and an accumulated deficit.
OTC.Pink
Alixo-Yolloo Corporation's Q3 2025 filing reveals a net loss and highlights concerns about the company's ability to continue as a going concern.